Description
IGF::CT::IGF BLOOD COMPATIBILITY TESTING 3 MONTH EXTENSION
Base award description: IGF::CL::IGF BLOOD COMPATIBILITY TESTING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-06-01+$504,456= $504,456
- Mod P000012012-11-29+$504,456= $1,008,912
- Mod P000022013-05-21+$252,228= $1,261,140
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-06-01 | +$504,456 | $504,456 | IGF::CL::IGF BLOOD COMPATIBILITY TESTING |
| Mod P00001· EXERCISE AN OPTION | 2012-11-29 | +$504,456 | $1,008,912 | IGF::CT::IGF BLOOD COMPATIBILITY TESTING |
| Mod P00002· EXERCISE AN OPTION | 2013-05-21 | +$252,228 | $1,261,140 | IGF::CT::IGF BLOOD COMPATIBILITY TESTING 3 MONTH EXTENSION |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI SX3XGHRJMNQ5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24826N0419 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $792,973 | FY2026 |
| 36C24826N0399 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6506 · BLOOD AND BLOOD PRODUCTS | $354,763 | FY2026 |
| 36C24826N0424 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $268,659 | FY2026 |
| 36C24826N0400 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $314,881 | FY2026 |
| 36C24826N0347 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $619,287 | FY2026 |
| 36C24826D0015 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
Other recipients under Q301 from 248-NETWORK CONTRACT OFFICE 8 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24816P1059 | QUEST DIAGNOSTICS INCORPORATED | 248-NETWORK CONTRACT OFFICE 8 | $306,851 | FY2016 |
| VA24816J0594 | QUEST DIAGNOSTICS INCORPORATED | 248-NETWORK CONTRACT OFFICE 8 | $1,200,000 | FY2016 |
| VA24816P0551 | NEUROSCIENCE ASSOCIATES INC | 248-NETWORK CONTRACT OFFICE 8 | $9,658 | FY2016 |
| VA24816F0121 | QUEST DIAGNOSTICS INCORPORATED | 248-NETWORK CONTRACT OFFICE 8 | $600,000 | FY2016 |
| VA24816P0117 | AMERICAN NATIONAL RED CROSS, THE | 248-NETWORK CONTRACT OFFICE 8 | $107,277 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24812C0236_3600_-NONE-_-NONE- · retrieved 2026-09-26.